Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

Special purpose acquisition company

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is listed on Nasdaq, where it has traded since February 25, 2025.

Type
Special purpose acquisition company
Listed On
Nasdaq
Listed Since
February 25, 2025
Market Cap
$263M

About Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp is a blank check company.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 23 institutions reported holding DMAA, with 12.0 million shares worth $124.9 million in aggregate. The largest reported holder was Karpus Management, with 2.5 million shares worth $26.7 million. Of the 5 largest holders listed below, 1 added shares and 4 reduced their positions during the quarter.

InstitutionSharesValueQuarter change
Karpus Management2,507,817$27MReduced 0.9%
Mizuho Securities USA2,069,605$22MAdded 3.48%
Polar Asset Management Partners1,146,000$12MReduced 28.38%
Glazer Capital999,899$11MReduced 40.43%
Wolverine Asset Management832,093$9MReduced 46.44%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is DMAA?

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is listed on Nasdaq, where it has traded since February 25, 2025.

Who are the largest institutional holders of DMAA?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of DMAA were Karpus Management, Mizuho Securities USA and Polar Asset Management Partners.

How many institutions own DMAA?

23 institutions reported a position in DMAA for the quarter ended June 30, 2026, worth $124.9 million in total.

Did institutions buy or sell DMAA last quarter?

Of the 5 largest reported holders, 1 added shares and 4 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for DMAA.

Every reported institutional holder, plus insider and congressional trades in DMAA, on SentiSense.